N3C Domain Team: Pharmacoepidemiology
The Pharmacoepidemiology Clinical Domain Team aims to help design the best scenarios for drugs already in use and to provide support for the best possible trials. The overall goal is to evaluate important, empirically testable hypotheses regarding the use, safety, and effectiveness of therapies for treating COVID-19 using a limited dataset from the N3C Data Enclave. These data will provide urgently needed information for deploying therapeutic agents to treat patients with COVID-19 infection.
Team meetings are held every other Monday at 4:00pm ET. Please email email@example.com to be added to the calendar invite.
Join the Conversation
Johns Hopkins Medicine
Johns Hopkins Bloomberg School of Public Health